Skip to Content

Broadridge’s 2026 Global Class Action Annual Report Spotlights GPWR’s Recent Achievements

Mon 2nd Mar 2026 | Posted by , on News

Broadridge’s 2026 Global Class Action Annual Report spotlights the “top 10 most complicated class action asset recovery opportunities of 2025”—including two matters our team litigated: Alibaba Group Holding Ltd. Securities Litigation ($433.5M) and ViacomCBS (Archegos) Securities Litigation ($120M). Congrats to the talented lawyers-Robert Prongay, Kara Wolke, Kevin Ruf, Melissa Wright, Pavithra Rajesh, Daniella Quitt, and Chris Fallon-whose efforts delivered these meaningful outcomes for investors. Link to the report: 2026 Global Class Action Annual Report

Glancy Prongay Wolke & Rotter LLP Ranked #2 in ISS SCAS “Top 50 Plaintiff Law Firms 2025” Report

Mon 23rd Feb 2026 | Posted by , on News

Glancy Prongay Wolke & Rotter LLP (formerly Glancy Prongay & Murray LLP) announced today that it has been ranked No. 2 nationally in Institutional Shareholder Services’ Securities Class Action Services (“ISS SCAS”) Top 50 Plaintiff Law Firms 2025 report, which ranks plaintiffs’ securities firms by the aggregate settlement amount achieved for shareholders in North American securities-related class action settlements during the 2025 calendar year. According to ISS SCAS, Glancy Prongay Wolke & Rotter achieved $585.9 million in total settlement funds approved by courts in 2025—placing the Firm second overall among plaintiffs’ firms. The Firm’s 2025 results included serving as Lead […]

Glancy Prongay Wolke & Rotter Scores Top Securities Settlement of 2025

Wed 4th Feb 2026 | Posted by , on News

Glancy Prongay Wolke & Rotter LLP (GPWR) is proud to announce that the Firm, as sole lead counsel for Alibaba investors, attained the highest securities class action settlement of 2025, according to prominent national economic consulting firm, NERA.  Spearheaded by partners Kara Wolke and Melissa Wright, GPWR leveraged its deep experience and tenacious advocacy into a $433.5 million settlement for the benefit of Alibaba’s investors.  Injured by fraud or corporate wrongdoing?  Let GPWR put its skills to work for you. As reported by NERA: Access the full report: Recent Trends in Securities Class Action Litigation: 2025 Full-Year Review 

Glancy Prongay & Murray LLP Announces Name Change To Glancy Prongay Wolke & Rotter LLP

Wed 28th Jan 2026 | Posted by , on News

Leading plaintiffs’ class action law firm Glancy Prongay & Murray LLP today announced that the Firm is changing its name to Glancy Prongay Wolke & Rotter LLP. The change reflects the substantial contributions that partners Kara Wolke, co-chair of the Firm’s securities litigation group, and Jonathan Rotter, chair of the Firm’s antitrust, consumer protection, and privacy groups, have made to the success of the Firm and the results that they have achieved for the Firm’s clients. Among these successes, Ms. Wolke led the Firm’s litigation team in a complex securities class action against Alibaba, achieving a $433.5 million settlement for investors, which ranks […]

Glancy Prongay & Murray Recognized as a 2025 Top Securities Litigation Boutique by Daily Journal

Wed 24th Dec 2025 | Posted by , on News

Glancy Prongay & Murray Recognized as a 2025 Top Securities Litigation Boutique by Daily Journal

Glancy Prongay & Murray LLP is honored to be recognized by the Daily Journal as one of California’s Top Securities Litigation Boutiques for 2025. For more than three decades, our firm has remained singularly focused on representing investors and consumers in complex, high-stakes securities matters nationwide. This profile highlights recent landmark recoveries, including our role as sole lead counsel in the $433.5 million Alibaba securities class action and as co-lead counsel in the $120 million ViacomCBS recovery arising from the Archegos collapse. We are grateful to our clients, colleagues, and team whose trust and dedication make these results possible.

Glancy Prongay & Murray LLP Secured $120 Million For Viacom Investors

Fri 19th Sep 2025 | Posted by , on News

On August 5, 2025, Co-Lead Counsel Glancy Prongay & Murray secured final approval of a $120 million settlement for ViacomCBS Inc. investors. The settlement resolves investors’ claims that certain underwriters of the March 2021 public offering of Viacom Class B and Viacom convertible preferred stock violated the Securities Act of 1933 by issuing false and misleading statements and failing to disclose that the underwriters had substantial holdings of Viacom common stock as collateral for a highly leveraged, highly concentrated portfolio owned by Archegos Capital Management LP and that the underwriters could (and did) sell those holdings when Archegos collapsed. The […]

GPM Announces Final Approval of a $20 Million Settlement on Behalf of Live Nation Investors

Mon 8th Sep 2025 | Posted by , on News

On August 28, 2025, Glancy Prongay & Murray LLP, as co-Class Counsel, secured final approval of a $20 million settlement on behalf of Live Nation Entertainment Inc. investors. The settlement resolves investors’ claims that Live Nation (NASDAQ: LIVE) violated the Securities Exchange Act of 1934 by allegedly misrepresenting its cooperation with regulators and its anti-competitive practices during the period February 23, 2022 and November 20, 2023. The case is in the United States District Court for the Central District of California, before Judge Kenly Kiya Kato, Case No. 23-cv-06343-KK-AS.

Glancy Prongay & Murray LLP Announces Federal Court Denial of Motion to Dismiss in Securities Fraud Case Against DermTech Executives

Mon 9th Jun 2025 | Posted by , on News

LOS ANGELES, June 9, 2025 – Glancy Prongay & Murray LLP (“GPM”) is pleased to announce that on June 5, 2025, the United States District Court for the Southern District of California denied in full Defendants’ motion to dismiss the Second Amended Consolidated Class Action Complaint in In re DermTech, Inc. Securities Litigation, Case No. 23-cv-1885-DMS-JLB. The case arises from allegations that former DermTech executives John Dobak and Kevin Sun made material misrepresentations or omissions concerning key aspects of the Company’s business. Specifically, Plaintiffs allege that Defendants misrepresented: (1) the extent to which Medicare covered the Company’s flagship product; (2) […]

Categories